Deeptope accelerates & de-risks the development of therapeutic proteins, using Deeptech high-throughput functional (in-vitro) assays to perform epitope & paratope mapping down to the nearest amino acid and multi-parametric IP free lead optimization in < 3 months. Deeptope is a CEA Saclay spinoff.

Contact: contact@deeptope.com

Website: www.deeptope.com